Literature DB >> 15897460

The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1.

Weiru Wang1, Chao Zhang, Adhirai Marimuthu, Heike I Krupka, Maryam Tabrizizad, Rafe Shelloe, Upasana Mehra, Kevin Eng, Hoa Nguyen, Calvin Settachatgul, Ben Powell, Michael V Milburn, Brian L West.   

Abstract

Steroidogenic factor-1 (SF-1) and liver receptor homologue-1 (LRH-1) belong to the fushi tarazu factor 1 subfamily of nuclear receptors. SF-1 is an essential factor for sex determination during development and regulates adrenal and gonadal steroidogenesis in the adult, whereas LRH-1 is a critical factor for development of endodermal tissues and regulates cholesterol and bile acid homeostasis. Regulatory ligands are unknown for SF-1 and LRH-1. A reported mouse LRH-1 structure revealed an empty pocket in a region commonly occupied by ligands in the structures of other nuclear receptors, and pocket-filling mutations did not alter the constitutive activity observed. Here we report the crystal structures of the putative ligand-binding domains of human SF-1 at 2.1-A resolution and human LRH-1 at 2.5-A resolution. Both structures bind a coactivator-derived peptide at the canonical activation-function surface, thus adopting the transcriptionally activating conformation. In human LRH-1, coactivator peptide binding also occurs to a second site. We discovered in both structures a phospholipid molecule bound in a pocket of the putative ligand-binding domain. MS analysis of the protein samples used for crystallization indicated that the two proteins associate with a range of phospholipids. Mutations of the pocket-lining residues reduced the transcriptional activities of SF-1 and LRH-1 in mammalian cell transfection assays without affecting their expression levels. These results suggest that human SF-1 and LRH-1 may be ligand-binding receptors, although it remains to be seen if phospholipids or possibly other molecules regulate SF-1 or LRH-1 under physiological conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15897460      PMCID: PMC1140416          DOI: 10.1073/pnas.0409482102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  67 in total

1.  Developmental expression of a novel Ftz-F1 homologue, ff1b (NR5A4), in the zebrafish Danio rerio.

Authors:  C Chai; W K Chan
Journal:  Mech Dev       Date:  2000-03-01       Impact factor: 1.882

2.  Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.

Authors:  J P Renaud; N Rochel; M Ruff; V Vivat; P Chambon; H Gronemeyer; D Moras
Journal:  Nature       Date:  1995-12-14       Impact factor: 49.962

3.  Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor.

Authors:  V Laudet
Journal:  J Mol Endocrinol       Date:  1997-12       Impact factor: 5.098

4.  25-Hydroxycholesterol is not a ligand for the orphan nuclear receptor steroidogenic factor-1 (SF-1).

Authors:  S H Mellon; S R Bair
Journal:  Endocrinology       Date:  1998-06       Impact factor: 4.736

5.  Phospholipid-assisted protein folding: phosphatidylethanolamine is required at a late step of the conformational maturation of the polytopic membrane protein lactose permease.

Authors:  M Bogdanov; W Dowhan
Journal:  EMBO J       Date:  1998-09-15       Impact factor: 11.598

6.  Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors.

Authors:  W Feng; R C Ribeiro; R L Wagner; H Nguyen; J W Apriletti; R J Fletterick; J D Baxter; P J Kushner; B L West
Journal:  Science       Date:  1998-06-12       Impact factor: 47.728

7.  Liver receptor homolog-1 stimulates the progesterone biosynthetic pathway during follicle-stimulating hormone-induced granulosa cell differentiation.

Authors:  Deeksha Saxena; Rachid Safi; Lynda Little-Ihrig; Anthony J Zeleznik
Journal:  Endocrinology       Date:  2004-04-29       Impact factor: 4.736

8.  SUMO modification of repression domains modulates function of nuclear receptor 5A1 (steroidogenic factor-1).

Authors:  Wei-Yi Chen; Wen-Chih Lee; Nai-Chi Hsu; Fu Huang; Bon-Chu Chung
Journal:  J Biol Chem       Date:  2004-06-10       Impact factor: 5.157

9.  Phospholipid scramblase 3 controls mitochondrial structure, function, and apoptotic response.

Authors:  Jihua Liu; Qiang Dai; Jun Chen; David Durrant; Angela Freeman; Tong Liu; Douglas Grossman; Ray M Lee
Journal:  Mol Cancer Res       Date:  2003-10       Impact factor: 5.852

10.  Specific pools of phospholipids are used for lipoprotein secretion by cultured rat hepatocytes.

Authors:  J E Vance; D E Vance
Journal:  J Biol Chem       Date:  1986-04-05       Impact factor: 5.157

View more
  60 in total

1.  Antidiabetic phospholipid-nuclear receptor complex reveals the mechanism for phospholipid-driven gene regulation.

Authors:  Paul M Musille; Manish Pathak; Janelle L Lauer; William H Hudson; Patrick R Griffin; Eric A Ortlund
Journal:  Nat Struct Mol Biol       Date:  2012-04-15       Impact factor: 15.369

Review 2.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

Review 3.  Emerging actions of the nuclear receptor LRH-1 in the gut.

Authors:  Pablo J Fernandez-Marcos; Johan Auwerx; Kristina Schoonjans
Journal:  Biochim Biophys Acta       Date:  2010-12-29

4.  Liver receptor homolog 1 is a negative regulator of the hepatic acute-phase response.

Authors:  Nicolas Venteclef; Jason C Smith; Bryan Goodwin; Philippe Delerive
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

5.  LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease.

Authors:  Agnes Coste; Laurent Dubuquoy; Romain Barnouin; Jean-Sebastien Annicotte; Benjamin Magnier; Mario Notti; Nadia Corazza; Maria Cristina Antal; Daniel Metzger; Pierre Desreumaux; Thomas Brunner; Johan Auwerx; Kristina Schoonjans
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-01       Impact factor: 11.205

6.  Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function.

Authors:  Lin Lin; Pascal Philibert; Bruno Ferraz-de-Souza; Daniel Kelberman; Tessa Homfray; Assunta Albanese; Veruska Molini; Neil J Sebire; Silvia Einaudi; Gerard S Conway; Ieuan A Hughes; J Larry Jameson; Charles Sultan; Mehul T Dattani; John C Achermann
Journal:  J Clin Endocrinol Metab       Date:  2007-01-02       Impact factor: 5.958

Review 7.  Extra-adrenal glucocorticoid synthesis in the intestinal epithelium: more than a drop in the ocean?

Authors:  Mario Noti; Daniel Sidler; Thomas Brunner
Journal:  Semin Immunopathol       Date:  2009-06-03       Impact factor: 9.623

Review 8.  Differentiation of mesenchymal stem cells into gonad and adrenal steroidogenic cells.

Authors:  Takashi Yazawa; Yoshitaka Imamichi; Kaoru Miyamoto; Akihiro Umezawa; Takanobu Taniguchi
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

9.  Solution Nuclear Magnetic Resonance Studies of the Ligand-Binding Domain of an Orphan Nuclear Receptor Reveal a Dynamic Helix in the Ligand-Binding Pocket.

Authors:  Nicolas Daffern; Zhonglei Chen; Yongbo Zhang; Leslie Pick; Ishwar Radhakrishnan
Journal:  Biochemistry       Date:  2018-03-22       Impact factor: 3.162

10.  Structure of SF-1 bound by different phospholipids: evidence for regulatory ligands.

Authors:  Elena P Sablin; Raymond D Blind; Irina N Krylova; Jared G Ingraham; Fang Cai; Jon D Williams; Robert J Fletterick; Holly A Ingraham
Journal:  Mol Endocrinol       Date:  2008-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.